CDC
WASHINGTON - CDC has confirmed the influenza neuraminidase N1 subtype of the U.S. case of human avian influenza A(H5) reported last week by genetic sequencing. Genetic characterization is ongoing and final data will be made publicly available in GenBankexternal icon as soon as available.
Background. A person has tested positive for avian influenza A(H5) virus (H5 bird flu) in the U.S., as reported by Colorado and confirmed by CDC. This case occurred in a person who had direct exposure to poultry and was involved in the culling (depopulating) of poultry with presumptive H5N1 bird flu. The patient reported fatigue for a few days as their only symptom and has since recovered. The patient is being isolated and treated with the influenza antiviral drug oseltamivir.
Click here to learn more.
Source: CDC.gov
Latest from Pest Control Technology
- Bug Busters Expands Service Footprint with New Georgia Branch
- Rodents Can Find Refuge from the Cold in Unused Vehicles
- Natasha Wright Discusses Winter Rodent Habits
- Truly Nolen Promotes Harush, Alvare
- Fleetio Report Finds 53.3% of Fleets Researching or Piloting AI Capabilities
- TRUCE Software Secures Series B Funding
- Richard Spencer Reviews Safety Standards and Training for Technicians
- Kimberly Camera, Canine Team are Hot on Rodent Trails
